[
  {
    "title": "OverviewNews ReleasesEvents & PresentationsGovernanceGovernance OverviewBoard of DirectorsLeadership TeamCommittee CompositionFinancialsSEC FilingsSto",
    "link": "https://kyvernatx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "OverviewNews ReleasesEvents & PresentationsGovernanceGovernance OverviewBoard of DirectorsLeadership TeamCommittee CompositionFinancialsSEC FilingsSto",
    "link": "https://kyvernatx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "OverviewNews ReleasesEvents & PresentationsGovernanceGovernance OverviewBoard of DirectorsLeadership TeamCommittee CompositionFinancialsSEC FilingsSto",
    "link": "https://ir.kyvernatx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Overview",
    "link": "https://ir.kyvernatx.com/",
    "timestamp": "unknown"
  },
  {
    "title": "News Releases",
    "link": "https://ir.kyvernatx.com/news-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Events & Presentations",
    "link": "https://ir.kyvernatx.com/presentations",
    "timestamp": "unknown"
  },
  {
    "title": "GovernanceGovernance OverviewBoard of DirectorsLeadership TeamCommittee Composition",
    "link": "https://ir.kyvernatx.com/corporate-governance/governance-overview",
    "timestamp": "unknown"
  },
  {
    "title": "Governance Overview",
    "link": "https://ir.kyvernatx.com/corporate-governance/governance-overview",
    "timestamp": "unknown"
  },
  {
    "title": "Board of Directors",
    "link": "https://kyvernatx.com/inside-kyverna/",
    "timestamp": "unknown"
  },
  {
    "title": "Leadership Team",
    "link": "https://kyvernatx.com/inside-kyverna/",
    "timestamp": "unknown"
  },
  {
    "title": "Committee Composition",
    "link": "https://ir.kyvernatx.com/corporate-governance/committee-composition",
    "timestamp": "unknown"
  },
  {
    "title": "FinancialsSEC Filings",
    "link": "https://ir.kyvernatx.com/financial-information/sec-filings",
    "timestamp": "unknown"
  },
  {
    "title": "SEC Filings",
    "link": "https://ir.kyvernatx.com/financial-information/sec-filings",
    "timestamp": "unknown"
  },
  {
    "title": "StockStock Quote & ChartAnalyst Coverage",
    "link": "https://ir.kyvernatx.com/stock-information/stock-quote-chart",
    "timestamp": "unknown"
  },
  {
    "title": "Stock Quote & Chart",
    "link": "https://ir.kyvernatx.com/stock-information/stock-quote-chart",
    "timestamp": "unknown"
  },
  {
    "title": "Analyst Coverage",
    "link": "https://ir.kyvernatx.com/stock-information/analyst-coverage",
    "timestamp": "unknown"
  },
  {
    "title": "IR ResourcesInvestor FAQsEmail AlertsContact IR",
    "link": "https://ir.kyvernatx.com/ir-resources/investor-faqs",
    "timestamp": "unknown"
  },
  {
    "title": "Investor FAQs",
    "link": "https://ir.kyvernatx.com/ir-resources/investor-faqs",
    "timestamp": "unknown"
  },
  {
    "title": "Email Alerts",
    "link": "https://ir.kyvernatx.com/ir-resources/email-alerts",
    "timestamp": "unknown"
  },
  {
    "title": "Contact IR",
    "link": "https://ir.kyvernatx.com/ir-resources/contact-ir",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "YearAll202520242023Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public compan",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public company, capital markets ",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public company, capital markets ",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public company, capital markets ",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public company, capital markets ",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public company, capital markets ",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Announces Appointment of New Chief Financial OfficerDr. Marc Grasso brings more than 25 years of public company, capital markets ",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Announces Appointment of New Chief Financial Officer",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "June 30, 2025PDF VersionRead More",
    "link": "https://ir.kyvernatx.com/node/7486/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "June 30, 2025PDF Version",
    "link": "https://ir.kyvernatx.com/node/7486/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7486/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7486/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-announces-appointment-new-chief-financial",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Jefferies Global Healthcare ConferenceEMERYVILLE, Calif. , May 28, 2025 /PRNewswire/ -- Kyverna Therapeutics, I",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-jefferies-global-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Jefferies Global Healthcare ConferenceEMERYVILLE, Calif. , May 28, 2025 /PRNewswire/ -- Kyverna Therapeutics, I",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-jefferies-global-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Jefferies Global Healthcare ConferenceEMERYVILLE, Calif. , May 28, 2025 /PRNewswire/ -- Kyverna Therapeutics, I",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-jefferies-global-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Jefferies Global Healthcare ConferenceEMERYVILLE, Calif. , May 28, 2025 /PRNewswire/ -- Kyverna Therapeutics, I",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-jefferies-global-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Jefferies Global Healthcare ConferenceEMERYVILLE, Calif. , May 28, 2025 /PRNewswire/ -- Kyverna Therapeutics, I",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-jefferies-global-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Jefferies Global Healthcare Conference",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-jefferies-global-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "May 28, 2025PDF VersionRead More",
    "link": "https://ir.kyvernatx.com/node/7436/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "May 28, 2025PDF Version",
    "link": "https://ir.kyvernatx.com/node/7436/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7436/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7436/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-jefferies-global-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-jefferies-global-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial ResultsEnrollment complete in registrational Phase 2 KYV-101 tr",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-0",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial ResultsEnrollment complete in registrational Phase 2 KYV-101 tr",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-0",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial ResultsEnrollment complete in registrational Phase 2 KYV-101 tr",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-0",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial ResultsEnrollment complete in registrational Phase 2 KYV-101 tr",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-0",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial ResultsEnrollment complete in registrational Phase 2 KYV-101 tr",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-0",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-0",
    "timestamp": "unknown"
  },
  {
    "title": "May 13, 2025PDF VersionRead More",
    "link": "https://ir.kyvernatx.com/node/7401/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "May 13, 2025PDF Version",
    "link": "https://ir.kyvernatx.com/node/7401/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7401/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7401/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-0",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-0",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial ResultsAccelerating clinical path to commerciali",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-fourth",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial ResultsAccelerating clinical path to commerciali",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-fourth",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial ResultsAccelerating clinical path to commerciali",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-fourth",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial ResultsAccelerating clinical path to commerciali",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-fourth",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial ResultsAccelerating clinical path to commerciali",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-fourth",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-fourth",
    "timestamp": "unknown"
  },
  {
    "title": "March 27, 2025PDF VersionRead More",
    "link": "https://ir.kyvernatx.com/node/7331/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "March 27, 2025PDF Version",
    "link": "https://ir.kyvernatx.com/node/7331/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7331/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7331/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-fourth",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-provides-business-update-and-reports-fourth",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma ConferenceEMERYVILLE, Calif. , March 3, 2025 /PRNewswire/ -- Kyverna Therapeu",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-leerink-partners-global-biopharma",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma ConferenceEMERYVILLE, Calif. , March 3, 2025 /PRNewswire/ -- Kyverna Therapeu",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-leerink-partners-global-biopharma",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma ConferenceEMERYVILLE, Calif. , March 3, 2025 /PRNewswire/ -- Kyverna Therapeu",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-leerink-partners-global-biopharma",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma ConferenceEMERYVILLE, Calif. , March 3, 2025 /PRNewswire/ -- Kyverna Therapeu",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-leerink-partners-global-biopharma",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma ConferenceEMERYVILLE, Calif. , March 3, 2025 /PRNewswire/ -- Kyverna Therapeu",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-leerink-partners-global-biopharma",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-leerink-partners-global-biopharma",
    "timestamp": "unknown"
  },
  {
    "title": "March 3, 2025PDF VersionRead More",
    "link": "https://ir.kyvernatx.com/node/7316/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "March 3, 2025PDF Version",
    "link": "https://ir.kyvernatx.com/node/7316/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7316/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7316/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-leerink-partners-global-biopharma",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-leerink-partners-global-biopharma",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development OfficerDr. Gehchan brings decades of successful late-stage clini",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-appoints-naji-gehchan-md-mba-chief-medical",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development OfficerDr. Gehchan brings decades of successful late-stage clini",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-appoints-naji-gehchan-md-mba-chief-medical",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development OfficerDr. Gehchan brings decades of successful late-stage clini",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-appoints-naji-gehchan-md-mba-chief-medical",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development OfficerDr. Gehchan brings decades of successful late-stage clini",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-appoints-naji-gehchan-md-mba-chief-medical",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development OfficerDr. Gehchan brings decades of successful late-stage clini",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-appoints-naji-gehchan-md-mba-chief-medical",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-appoints-naji-gehchan-md-mba-chief-medical",
    "timestamp": "unknown"
  },
  {
    "title": "January 21, 2025PDF VersionRead More",
    "link": "https://ir.kyvernatx.com/node/7286/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "January 21, 2025PDF Version",
    "link": "https://ir.kyvernatx.com/node/7286/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7286/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7286/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-appoints-naji-gehchan-md-mba-chief-medical",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-appoints-naji-gehchan-md-mba-chief-medical",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare ConferenceExtending Comp",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-highlight-near-term-strategic-priorities",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare ConferenceExtending Comp",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-highlight-near-term-strategic-priorities",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare ConferenceExtending Comp",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-highlight-near-term-strategic-priorities",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare ConferenceExtending Comp",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-highlight-near-term-strategic-priorities",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare ConferenceExtending Comp",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-highlight-near-term-strategic-priorities",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare Conference",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-highlight-near-term-strategic-priorities",
    "timestamp": "unknown"
  },
  {
    "title": "January 13, 2025PDF VersionRead More",
    "link": "https://ir.kyvernatx.com/node/7276/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "January 13, 2025PDF Version",
    "link": "https://ir.kyvernatx.com/node/7276/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7276/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7276/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-highlight-near-term-strategic-priorities",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-highlight-near-term-strategic-priorities",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare ConferenceEMERYVILLE, Calif. , Jan. 6, 2025 /PRNewswire/ -- Kyverna Therape",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-43rd-annual-j-p-morgan-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare ConferenceEMERYVILLE, Calif. , Jan. 6, 2025 /PRNewswire/ -- Kyverna Therape",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-43rd-annual-j-p-morgan-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare ConferenceEMERYVILLE, Calif. , Jan. 6, 2025 /PRNewswire/ -- Kyverna Therape",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-43rd-annual-j-p-morgan-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare ConferenceEMERYVILLE, Calif. , Jan. 6, 2025 /PRNewswire/ -- Kyverna Therape",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-43rd-annual-j-p-morgan-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare ConferenceEMERYVILLE, Calif. , Jan. 6, 2025 /PRNewswire/ -- Kyverna Therape",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-43rd-annual-j-p-morgan-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare Conference",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-43rd-annual-j-p-morgan-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "January 6, 2025PDF VersionRead More",
    "link": "https://ir.kyvernatx.com/node/7261/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "January 6, 2025PDF Version",
    "link": "https://ir.kyvernatx.com/node/7261/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7261/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "PDF Version",
    "link": "https://ir.kyvernatx.com/node/7261/pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-43rd-annual-j-p-morgan-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Read More",
    "link": "https://ir.kyvernatx.com/news-releases/news-release-details/kyverna-therapeutics-present-43rd-annual-j-p-morgan-healthcare",
    "timestamp": "unknown"
  },
  {
    "title": "Investor ContactdraftsInvestorRelations@kyvernatx.comdraftsMedia@kyvernatx.comphone_iphone+1 510.925.2492Subscribe to our Email AlertsSubscribe",
    "link": "mailto:InvestorRelations@kyvernatx.com",
    "timestamp": "unknown"
  },
  {
    "title": "Investor ContactdraftsInvestorRelations@kyvernatx.comdraftsMedia@kyvernatx.comphone_iphone+1 510.925.2492Subscribe to our Email AlertsSubscribe",
    "link": "mailto:InvestorRelations@kyvernatx.com",
    "timestamp": "unknown"
  },
  {
    "title": "Investor ContactdraftsInvestorRelations@kyvernatx.comdraftsMedia@kyvernatx.comphone_iphone+1 510.925.2492Subscribe to our Email AlertsSubscribe",
    "link": "mailto:InvestorRelations@kyvernatx.com",
    "timestamp": "unknown"
  },
  {
    "title": "Investor ContactdraftsInvestorRelations@kyvernatx.comdraftsMedia@kyvernatx.comphone_iphone+1 510.925.2492Subscribe to our Email AlertsSubscribe",
    "link": "mailto:InvestorRelations@kyvernatx.com",
    "timestamp": "unknown"
  },
  {
    "title": "Investor ContactdraftsInvestorRelations@kyvernatx.comdraftsMedia@kyvernatx.comphone_iphone+1 510.925.2492",
    "link": "mailto:InvestorRelations@kyvernatx.com",
    "timestamp": "unknown"
  },
  {
    "title": "Investor ContactdraftsInvestorRelations@kyvernatx.comdraftsMedia@kyvernatx.comphone_iphone+1 510.925.2492",
    "link": "mailto:InvestorRelations@kyvernatx.com",
    "timestamp": "unknown"
  },
  {
    "title": "Investor ContactdraftsInvestorRelations@kyvernatx.comdraftsMedia@kyvernatx.comphone_iphone+1 510.925.2492",
    "link": "mailto:InvestorRelations@kyvernatx.com",
    "timestamp": "unknown"
  },
  {
    "title": "Investor ContactdraftsInvestorRelations@kyvernatx.comdraftsMedia@kyvernatx.comphone_iphone+1 510.925.2492",
    "link": "mailto:InvestorRelations@kyvernatx.com",
    "timestamp": "unknown"
  },
  {
    "title": "Investor ContactdraftsInvestorRelations@kyvernatx.comdraftsMedia@kyvernatx.comphone_iphone+1 510.925.2492",
    "link": "mailto:InvestorRelations@kyvernatx.com",
    "timestamp": "unknown"
  },
  {
    "title": "draftsInvestorRelations@kyvernatx.com",
    "link": "mailto:InvestorRelations@kyvernatx.com",
    "timestamp": "unknown"
  },
  {
    "title": "draftsMedia@kyvernatx.com",
    "link": "mailto:media@kyvernatx.com",
    "timestamp": "unknown"
  },
  {
    "title": "\u00a9 2025 Kyverna TherapeuticsSocial MediaLinkedIn opens in new windowGlassdoor opens in new window",
    "link": "https://www.linkedin.com/company/kyverna/",
    "timestamp": "unknown"
  },
  {
    "title": "\u00a9 2025 Kyverna TherapeuticsSocial MediaLinkedIn opens in new windowGlassdoor opens in new window",
    "link": "https://www.linkedin.com/company/kyverna/",
    "timestamp": "unknown"
  },
  {
    "title": "\u00a9 2025 Kyverna TherapeuticsSocial MediaLinkedIn opens in new windowGlassdoor opens in new window",
    "link": "https://www.linkedin.com/company/kyverna/",
    "timestamp": "unknown"
  },
  {
    "title": "Social MediaLinkedIn opens in new windowGlassdoor opens in new window",
    "link": "https://www.linkedin.com/company/kyverna/",
    "timestamp": "unknown"
  },
  {
    "title": "Social MediaLinkedIn opens in new windowGlassdoor opens in new window",
    "link": "https://www.linkedin.com/company/kyverna/",
    "timestamp": "unknown"
  },
  {
    "title": "LinkedIn opens in new window",
    "link": "https://www.linkedin.com/company/kyverna/",
    "timestamp": "unknown"
  },
  {
    "title": "Glassdoor opens in new window",
    "link": "https://www.glassdoor.com/Overview/Working-at-Kyverna-Therapeutics-EI_IE6483224.11,31.htm",
    "timestamp": "unknown"
  }
]